UA93254C2 - Способ получения препарата инсулина для перорального применения - Google Patents
Способ получения препарата инсулина для перорального примененияInfo
- Publication number
- UA93254C2 UA93254C2 UAA200900222A UAA200900222A UA93254C2 UA 93254 C2 UA93254 C2 UA 93254C2 UA A200900222 A UAA200900222 A UA A200900222A UA A200900222 A UAA200900222 A UA A200900222A UA 93254 C2 UA93254 C2 UA 93254C2
- Authority
- UA
- Ukraine
- Prior art keywords
- insulin preparation
- ranges
- producing insulin
- insulin
- peroral use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2006132763/15A RU2316339C1 (ru) | 2006-09-13 | 2006-09-13 | Способ получения препарата инсулина для перорального применения |
Publications (1)
Publication Number | Publication Date |
---|---|
UA93254C2 true UA93254C2 (ru) | 2011-01-25 |
Family
ID=39184228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200900222A UA93254C2 (ru) | 2006-09-13 | 2007-11-09 | Способ получения препарата инсулина для перорального применения |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090312235A1 (ru) |
EP (1) | EP2067484A4 (ru) |
JP (1) | JP2010503665A (ru) |
CN (1) | CN101384276A (ru) |
AU (1) | AU2007295132A1 (ru) |
CA (1) | CA2662799A1 (ru) |
EA (1) | EA012884B1 (ru) |
IL (1) | IL197470A0 (ru) |
MX (1) | MX2009001286A (ru) |
RU (1) | RU2316339C1 (ru) |
UA (1) | UA93254C2 (ru) |
WO (1) | WO2008033058A2 (ru) |
ZA (1) | ZA200807272B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA90013C2 (ru) | 2008-03-19 | 2010-03-25 | Давид Анатолійович Нога | Фармацевтическая композиция, содержащая инсулин, и способ его получения |
RU2395296C1 (ru) * | 2009-02-19 | 2010-07-27 | Общество С Ограниченной Ответственностью "Концерн О3" | Способ получения препарата проинсулина для перорального применения |
RU2452509C1 (ru) * | 2011-01-31 | 2012-06-10 | Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" ООО "Саентифик Фьючер Менеджмент" | Средство для стимуляции роста организма |
RU2646475C2 (ru) * | 2011-12-12 | 2018-03-05 | МЕЛИОР ФАРМАСЬЮТИКАЛЗ Ай, ИНК. | Лечение диабета I и II типа |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2066551C1 (ru) * | 1994-03-23 | 1996-09-20 | Институт нефтехимического синтеза РАН | Способ получения инсулинсодержащих полимерных гидрогелей |
RU2117488C1 (ru) * | 1997-07-30 | 1998-08-20 | Институт нефтехимического синтеза им.А.В.Топчиева РАН | Твердое инсулинсодержащее лекарственное средство |
RU2213557C2 (ru) * | 2001-12-26 | 2003-10-10 | Закрытое акционерное общество "Аксис" | Фармацевтическая композиция, обладающая тромболитическими, противовоспалительными и цитопротективными свойствами |
-
2006
- 2006-09-13 RU RU2006132763/15A patent/RU2316339C1/ru active IP Right Revival
-
2007
- 2007-09-11 CA CA002662799A patent/CA2662799A1/en not_active Abandoned
- 2007-09-11 MX MX2009001286A patent/MX2009001286A/es unknown
- 2007-09-11 EA EA200801259A patent/EA012884B1/ru not_active IP Right Cessation
- 2007-09-11 JP JP2009528195A patent/JP2010503665A/ja not_active Withdrawn
- 2007-09-11 EP EP07834992A patent/EP2067484A4/de not_active Withdrawn
- 2007-09-11 CN CNA2007800060392A patent/CN101384276A/zh active Pending
- 2007-09-11 US US12/310,892 patent/US20090312235A1/en not_active Abandoned
- 2007-09-11 AU AU2007295132A patent/AU2007295132A1/en not_active Abandoned
- 2007-09-11 WO PCT/RU2007/000483 patent/WO2008033058A2/ru active Application Filing
- 2007-11-09 UA UAA200900222A patent/UA93254C2/ru unknown
-
2008
- 2008-08-22 ZA ZA200807272A patent/ZA200807272B/xx unknown
-
2009
- 2009-03-08 IL IL197470A patent/IL197470A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2067484A2 (de) | 2009-06-10 |
EA012884B1 (ru) | 2009-12-30 |
MX2009001286A (es) | 2009-03-20 |
JP2010503665A (ja) | 2010-02-04 |
CN101384276A (zh) | 2009-03-11 |
EP2067484A4 (de) | 2009-10-28 |
WO2008033058A2 (fr) | 2008-03-20 |
EA200801259A1 (ru) | 2008-08-29 |
IL197470A0 (en) | 2011-08-01 |
RU2316339C1 (ru) | 2008-02-10 |
US20090312235A1 (en) | 2009-12-17 |
CA2662799A1 (en) | 2008-03-20 |
ZA200807272B (en) | 2009-07-29 |
AU2007295132A1 (en) | 2008-03-20 |
WO2008033058A3 (fr) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118222T1 (el) | Συνθεσεις λυασης φαινυλαλανινης αμμωνιας προκαρυωτικων και μεθοδοι αγωγης καρκινου χρησιμοποιωντας συνθεσεις εξ' αυτης | |
JO2932B1 (en) | Lyspro insulin compounds linked to PEG | |
NZ616304A (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
EA200801460A1 (ru) | Рекомбинантные моновалентные антитела и способы их получения | |
TW200732447A (en) | Adhesive formulation, method for the production thereof, and use thereof | |
PL410218A1 (pl) | Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie | |
ES2622228T3 (es) | Vacunas antivíricas dirigidas a células presentadoras de antígenos | |
EA201171481A1 (ru) | Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения | |
MX342551B (es) | Region constante de anticuerpo modificada. | |
MX369784B (es) | Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr). | |
WO2007100902A3 (en) | Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation | |
WO2009104074A3 (en) | Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells | |
SG148997A1 (en) | Powders comprising low molecular dextran and methods of producing those powders | |
ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
MX342643B (es) | Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona). | |
MY153908A (en) | Improved antibody molecules | |
EA201170038A1 (ru) | Загруженные лекарственным средством полимерные наночастицы и способы их получения и применения | |
TW200806315A (en) | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions | |
UA93254C2 (ru) | Способ получения препарата инсулина для перорального применения | |
WO2013012961A3 (en) | Sugar alcohol-based crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof | |
EP1670450B8 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
CN103030813B (zh) | 一种壳聚糖接枝聚乙烯亚胺非病毒转基因载体的制备方法 | |
WO2009152147A3 (en) | Compositions and methods for dengue virus (dv) treatment and vaccination | |
IL176171A0 (en) | N-aryl piperidine substituted biphenylcarboxamides |